KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Tax ProvisionsTax Rate
Others
Ratios

BioNTech SE (BNTX) Income towards Parent Company (2018 - 2025)

Historic Income towards Parent Company for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to $91.3 million.

  • BioNTech SE's Income towards Parent Company fell 3031.23% to $91.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$417.3 million, marking a year-over-year increase of 2857.8%. This contributed to the annual value of -$737.4 million for FY2024, which is 17367.4% down from last year.
  • As of Q3 2025, BioNTech SE's Income towards Parent Company stood at $91.3 million, which was down 3031.23% from -$437.6 million recorded in Q2 2025.
  • Over the past 5 years, BioNTech SE's Income towards Parent Company peaked at $7.1 billion during Q1 2022, and registered a low of -$865.6 million during Q2 2024.
  • Moreover, its 5-year median value for Income towards Parent Company was $366.4 million (2024), whereas its average is $1.4 billion.
  • As far as peak fluctuations go, BioNTech SE's Income towards Parent Company soared by 6418573663.12% in 2022, and later plummeted by 31749.74% in 2024.
  • Quarter analysis of 5 years shows BioNTech SE's Income towards Parent Company stood at $3622.0 in 2021, then surged by 64185736.63% to $2.3 billion in 2022, then crashed by 78.81% to $492.7 million in 2023, then dropped by 25.63% to $366.4 million in 2024, then crashed by 75.08% to $91.3 million in 2025.
  • Its Income towards Parent Company was $91.3 million in Q3 2025, compared to -$437.6 million in Q2 2025 and -$437.4 million in Q1 2025.